PYXS
Pyxis Oncology, Inc.
$2.46
-0.17 (-6.46%)
At close · Jul 6
Market Cap
$187.22M
Shares
63,355,482
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-02 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-15 | — | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K/A | 2026-04-30 | 2026-02-06 | |
| DEF 14A | 2026-04-30 | — | |
| 10-K | 2026-03-23 | 2025-12-31 | |
| 8-K | 2026-03-23 | — | |
| 8-K | 2026-02-06 | — | |
| 8-K | 2025-12-18 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-07-03 | 2025-07-01 | |
| 8-K | 2025-06-18 | — | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | — | |
| 8-K | 2025-03-24 | — | |
| 8-K | 2025-03-18 | — | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-02-04 | — | |
| 8-K | 2024-12-19 | — | |
| 8-K | 2024-11-20 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-10-23 | — | |
| DEF 14A | 2024-09-25 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-14 | — | |
| 8-K | 2024-06-12 | 2024-06-11 | |
| 8-K | 2024-06-10 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-14 | — | |
| DEF 14A | 2024-04-26 | 2024-06-11 | |
| 8-K | 2024-03-27 | — | |
| 8-K | 2024-03-27 | — | |
| 8-K | 2024-03-21 | — | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-13 | 2024-03-12 | |
| 8-K | 2024-02-28 | 2024-02-26 | |
| 8-K | 2023-11-28 | 2023-11-27 | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K/A | 2023-10-27 | 2023-08-23 | |
| 8-K | 2023-08-23 | — |
Showing 1–50 of 81 filings